Microwave Ablation Feasible for T1N0M0 Papillary Thyroid Carcinoma

FRIDAY, April 12, 2024 -- For patients with multifocal papillary thyroid carcinoma (PTC), the rates of progression-free survival (PFS) do not differ between microwave ablation (MWA) and surgical resection (SR), according to a study published online...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news